Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Acute Inflammation II: Cellular Phase01:26

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Development of the Lymphatic System01:15

Development of the Lymphatic System

The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tunable gene control via RNA splicing with a clinically approved small molecule.

Nature communications·2026
Same author

Deletion of Lymphatic PD-L1 Protects Mice From Severe Autoimmune Encephalitis.

European journal of immunology·2026
Same author

An unbiased whole-genome open reading frame overexpression screen identifies B3GALT2, a novel inducer of cellular ASO activity.

Molecular therapy. Nucleic acids·2025
Same author

Transcriptomics- and 3D imaging-based characterization of the lymphatic vasculature in human skin.

The Journal of experimental medicine·2025
Same author

Enzyme Activity-Based Genome-wide Screening for Modifiers of Lysosomal Glucocerebrosidase Uncovers Candidate Risk Factors for Parkinson's Disease.

ACS central science·2025
Same author

Defining the Cis-Regulatory Elements of SCN1A in GABAergic Interneurons.

Molecular neurobiology·2025

Related Experiment Video

Updated: May 26, 2026

Blocking Lymph Flow by Suturing Afferent Lymphatic Vessels in Mice
05:59

Blocking Lymph Flow by Suturing Afferent Lymphatic Vessels in Mice

Published on: May 14, 2020

Inflammation-induced lymph node lymphangiogenesis is reversible.

Viviane Mumprecht1, Filip Roudnicky1, Michael Detmar1

  • 1Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland.

The American Journal of Pathology
|December 28, 2011
PubMed
Summary

Lymph node lymphangiogenesis, an early sign of metastasis, can be imaged using anti-LYVE-1 immuno-PET. This study confirms that inflammation-induced lymphatic vessel expansion in lymph nodes regresses upon inflammation resolution.

More Related Videos

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

Digestion of the Murine Liver for a Flow Cytometric Analysis of Lymphatic Endothelial Cells
08:07

Digestion of the Murine Liver for a Flow Cytometric Analysis of Lymphatic Endothelial Cells

Published on: January 7, 2019

Related Experiment Videos

Last Updated: May 26, 2026

Blocking Lymph Flow by Suturing Afferent Lymphatic Vessels in Mice
05:59

Blocking Lymph Flow by Suturing Afferent Lymphatic Vessels in Mice

Published on: May 14, 2020

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

Digestion of the Murine Liver for a Flow Cytometric Analysis of Lymphatic Endothelial Cells
08:07

Digestion of the Murine Liver for a Flow Cytometric Analysis of Lymphatic Endothelial Cells

Published on: January 7, 2019

Area of Science:

  • Oncology
  • Immunology
  • Medical Imaging

Background:

  • Lymph node metastasis extent predicts cancer progression.
  • Current noninvasive imaging lacks sensitivity for early metastasis detection.
  • Lymphangiogenesis in lymph nodes may be an early indicator of metastasis.

Purpose of the Study:

  • To investigate if inflammation-induced lymph node lymphangiogenesis resolves after inflammation subsides.
  • To determine if anti-LYVE-1 immuno-PET can detect the regression of lymphatic vessels.
  • To differentiate between inflammation-induced and metastasis-induced lymphangiogenesis.

Main Methods:

  • Developed and utilized anti-LYVE-1 immuno-PET for imaging lymph node lymphangiogenesis in mice.
  • Established a mouse model of skin inflammation to study lymphatic vessel changes.
  • Monitored lymphatic network changes in lymph nodes during and after inflammation resolution.

Main Results:

  • Lymphatic vessels in tumor-draining lymph nodes showed regression upon resolution of inflammation.
  • Anti-LYVE-1 immuno-PET successfully visualized the regression of lymphatic networks.
  • Demonstrated that inflammation-induced lymphangiogenesis is reversible.

Conclusions:

  • Lymph node lymphangiogenesis induced by inflammation is a transient process.
  • Anti-LYVE-1 immuno-PET is a sensitive tool for detecting lymph node lymphangiogenesis and its regression.
  • This finding is crucial for accurately identifying lymph node metastasis in cancer patients.